Brief: NeuBase Therapeutics Reports Q3 Loss Per Share $0.18
13/08/2020 21:41
Aug 13 (Reuters) - NeuBase Therapeutics Inc NBSE.O :
* NEUBASE THERAPEUTICS REPORTS FINANCIAL RESULTS FOR THE
THIRD
FISCAL QUARTER OF 2020
* Q3 LOSS PER SHARE $0.18
* Q3 EARNINGS PER SHARE ESTIMATE $-0.23 -- REFINITIV IBES
DATA
Source text for Eikon: ID:nGNX54dK33
Further company coverage: NBSE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NeuBase Therapeutics
See all newsBrief: Neubase Therapeutics, On May 2, Was Notified By Nasdaq On Not Regained Compliance With Minimum Bid Price Requirement
Brief: Neubase Therapeutics Announces Receipt Of Notice From Nasdaq
U.S. STOCKS ON THE MOVE-TPG, R1 RCM, Zoom
U.S. STOCKS ON THE MOVE-Micron, Krystal Biotech, Pilgrim's Pride
U.S. STOCKS ON THE MOVE-Domino's Pizza, Voyager, Freshpet